Vincent Hs Chang

Vincent Hs Chang

Auto-generated profile, based on publicly available information

Vincent Hs Chang


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2022 in JID Innovations
Verified
Journal Article
Open access
CLChing-Wen Lin
Ching-Wen Lin
CCChih-Chiang Chen
Chih-Chiang Chen
WHWen-Yen Huang
Wen-Yen Huang
YCYen-Yu Chen
Yen-Yu Chen
SCShiou-Ting Chen
Shiou-Ting Chen
SCShun-Cheng Chang
Shun-Cheng Chang
Diabetic wounds exhibit chronic inflammation and delayed tissue proliferation or remodeling, mainly owing to prolonged proinflammatory (M1) macrophage activity and defects in transition to prohealing/proremodeling (M2a/M2c; CD206+ and/or CD163+) macrophages. We found that topical treatment with ON101, a plant-based potential therapeutic for diabetic foot ulcers, increased M2c-like (CD163+ and CD206+) cells and suppressed M1-like cells, altering the inflammatory gene profile in a diabetic mouse model compared with that in the controls. An in vitro macrophage-polarizing model revealed that ON101 directly suppressed CD80+ and CD86+ M1-macrophage polarization and M1-associated proinflammatory cytokines at both protein and transcriptional levels. Notably, conditioned medium collected from ON101-treated M1 macrophages reversed the M1-conditioned medium‒mediated suppression of CD206+ macrophages. Furthermore, conditioned medium from ON101-treated adipocyte progenitor cells significantly promoted CD206+ and CD163+ macrophages but strongly inhibited M1-like cells. ON101 treatment also stimulated the expression of GCSF and CXCL3 genes in human adipocyte progenitor cells. Interestingly, treatment with recombinant GCSF protein enhanced both CD206+ and CD163+ M2 markers, whereas CXCL3 treatment only stimulated CD163+ M2 macrophages. Depletion of cutaneous M2 macrophages inhibited ON101-induced diabetic wound healing. Thus, ON101 directly suppressed M1 macrophages and facilitated the GCSF- and CXCL3-mediated transition from M1 to M2 macrophages, lowering inflammation and leading to faster diabetic wound healing.

21 January 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YYYu-Chen S. H. Yang
Yu-Chen S. H. Yang
HCHsuen-Wen Chang
Hsuen-Wen Chang
ILI-Hsuan Lin
I-Hsuan Lin
LCLi-Nien Chien
Li-Nien Chien
MWMin-Ju Wu
Min-Ju Wu
YYYun Yen
Yun Yen
Proton pump inhibitors (PPIs) are used for the long-term treatment of gastroesophageal disorders and the non-prescription medicines for acid reflux. However, there is growing concerns about PPI misuse, overuse and abuse. This study aimed to develop an animal model to examine the effects of long-term use of PPI in vivo. Twenty one Wistar rats were given omeprazole orally or intravenously for 30 days, and caerulein as a positive control. After euthanization, the serum and stool were collected to perform MS-based quantitative analysis of metabolites. We carried out 16S-based profiling of fecal microbiota, assessed the expression of bile acid metabolism regulators and examined the immunopathological characteristics of bile ducts. After long-term PPI exposure, the fecal microbial profile was altered and showed similarity to those observed in high-fat diet studies. The concentrations of several metabolites were also changed in various specimens. Surprisingly, morphological changes were observed in the bile duct, including ductal epithelial proliferation, micropapillary growth of biliary epithelium, focal bile duct stricture formation and bile duct obstruction. These are characteristics of precancerous lesions of bile duct. FXR and RXRα expressions were significantly reduced, which were similar to that observed in cholangiocarcinoma in TCGA and Oncomine databases. We established a novel animal model to examine the effects of long-term use of omeprazole. The gut microbes and metabolic change are consequences of long-term PPI exposure. And the results showed the environment in vivo tends to a high-fat diet. More importantly, we observed biliary epithelial hyperplasia, which is an indicator of a high-fat diet.

4 February 2014 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
SGShikha Gaur
Shikha Gaur
LCLinling Chen
Linling Chen
VAVincent Ann
Vincent Ann
WLWei-Chen Lin
Wei-Chen Lin
YWYafan Wang
Yafan Wang
YYYun Yen
Yun Yen
Cancer is the result of a multistep process of genomic alterations, including mutations in key regulatory proteins that result in loss of balanced gene expression and subsequent malignant transformation. Throughout the various stages of colorectal carcinoma (CRC), complex genetic alterations occur, of which over-expression of growth factors, such as vascular endothelial growth factor, fibroblast growth factor and platelet-derive growth factor and their corresponding receptor tyrosine kinases, have been shown to correlate with invasiveness, tumor angiogenesis, metastasis, recurrence, and poor prognosis of colorectal cancer. To evaluate the therapeutic effect, we combined Dovitinib, an orally bioavailable, potent inhibitor of class III-V receptor tyrosine kinases with chemotherapeutic drug, oxaliplatin in preclinical models of colon cancer.

19 September 2017 in Biomedical Microdevices
Verified
Journal Article
Closed access
PDF file
Kuo-Yuan HwaKuo-Yuan Hwa
Kuo-Yuan Hwa
VCVincent H. S. Chang
Vincent H. S. Chang
YCYao-Yi Cheng
Yao-Yi Cheng
YWYue-Da Wang
Yue-Da Wang
PJPey-Shynan Jan
Pey-Shynan Jan
BWBo-Kai Wang
Bo-Kai Wang

1 October 2016 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
LHLiang-Ti Huang
Liang-Ti Huang
HCHsuen-Wen Chang
Hsuen-Wen Chang
MWMin-Ju Wu
Min-Ju Wu
YLYong-Tzuo Lai
Yong-Tzuo Lai
WWWen-Chi Wu
Wen-Chi Wu
VCVincent H.S. Chang
Vincent H.S. Chang

7 February 2019 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
CLChiming Lee
Chiming Lee
JLJiahnhaur Liao
Jiahnhaur Liao
SCSeuhwa Chen
Seuhwa Chen
CYChiaohan Yen
Chiaohan Yen
YLYuchieh Lee
Yuchieh Lee
VCVincent Hungshu Chang
Vincent Hungshu Chang
Inflammation is the first step that leads to inflammatory cell migration, cytokine release, and myofibroblast formation. Myofibroblasts can deposit excess amounts of extracellular matrix. Cyclooxygenase (COX) inhibitor exhibits strong anti-inflammatory response; however, this is usually achieved with undesirable side effects. In this study, we demonstrated the effects of the fluorine-modified rutaecarpine (RUT), fluoro-2-methoxyrutaecarpine (F-RUT), in inflammatory damage in the lungs. Based on the results, F-RUT retained anti-inflammatory activity both in vitro and in vivo in lungs. Compared to the parent compound, F-RUT showed better COX-2 suppression as a COX-2-selective inhibitor with lower cytotoxicity, and enhanced molecular reactivity and biological activity. F-RUT was also observed to reduce reactive oxygen species (ROS) generation and inflammatory infiltrating neutrophils in lipopolysaccharide (LPS)-stimulated zebrafish and ovalbumin (OVA)/alum-challenged KLF-10-knockout mouse lungs, respectively. Furthermore, F-RUT ameliorated the respiratory function in OVA/alum-challenged BALB/c mice by maintaining the thickness of the blood-air barrier in mouse lungs. Overall, these data suggest that F-RUT may function as an effective therapeutic agent for inflammation-induced lung dysfunction, and a better selection for pharmaceutical purposes than conventionally used anti-inflammatory agents.